Pontine glioma. To biopsy or not to biopsy: That is the question

British Journal of Neurosurgery

Volumn 22, Issue 5, 2008, Pages 624-

  Hargrave, Darren ^a  

^a ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ERLOTINIB; IMATINIB;

BRAIN BIOPSY; BRAIN TUMOR; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL RESEARCH; DIFFUSE INTRINSIC PONTINE GLIOMA; DIFFUSE PONTINE TUMOR; GLIOMA; HUMAN; MEDICAL ETHICS; NEUROIMAGING; NEUROSURGERY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOLOGY; PATIENT SAFETY; PEDIATRIC SURGERY; PRIORITY JOURNAL; PROGNOSIS; TUMOR DIAGNOSIS;

BIOPSY; BRAIN STEM; BRAIN STEM NEOPLASMS; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS;

EID: 56549083947     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.1080/02688690802484405     Document Type: Note

References (3)

1. Hargrave D, Bartels U, Bouffet E. Diffuse brainstem glioma in children: critical review of clinical trials. Lancet Oncol 2006;7(3):241-8.
2. Albright AL, Packer RJ, Zimmerman R, Rorke LB, Boyett J, Hammond GD. Magnetic resonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas: a report from the Children's Cancer Group. Neurosurgery 1993;33:1026-9.
3. Hargrave D, Ndiaye A, Frappaz D, et al. ITCC phase I study of erlotonib in children with refractory and relapsed malignant brain tumours and combined with irradiation in newly diagnosed brainstem glioma. NeuroOncol 2008;advanced online publication.